-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Cardiovascular Systems, Inc. (NASDAQ:CSII) Short Interest Up 17.9% in July
Cardiovascular Systems, Inc. (NASDAQ:CSII) Short Interest Up 17.9% in July
Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) saw a significant growth in short interest in the month of July. As of July 31st, there was short interest totalling 1,450,000 shares, a growth of 17.9% from the July 15th total of 1,230,000 shares. Based on an average trading volume of 345,500 shares, the short-interest ratio is presently 4.2 days. Approximately 4.3% of the shares of the company are short sold.
Insider Buying and Selling at Cardiovascular Systems
In other news, CFO Jeffrey S. Points purchased 3,000 shares of the firm's stock in a transaction on Friday, May 20th. The stock was bought at an average cost of $14.50 per share, for a total transaction of $43,500.00. Following the completion of the acquisition, the chief financial officer now directly owns 109,312 shares of the company's stock, valued at $1,585,024. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 3.00% of the company's stock.
Get Cardiovascular Systems alerts:Institutional Investors Weigh In On Cardiovascular Systems
Several hedge funds have recently made changes to their positions in the stock. Signaturefd LLC lifted its stake in Cardiovascular Systems by 8,110.3% during the first quarter. Signaturefd LLC now owns 2,381 shares of the medical device company's stock worth $54,000 after purchasing an additional 2,352 shares during the period. Acadian Asset Management LLC lifted its stake in Cardiovascular Systems by 294.7% during the fourth quarter. Acadian Asset Management LLC now owns 2,684 shares of the medical device company's stock worth $50,000 after purchasing an additional 2,004 shares during the period. PNC Financial Services Group Inc. lifted its stake in Cardiovascular Systems by 32.1% during the first quarter. PNC Financial Services Group Inc. now owns 3,025 shares of the medical device company's stock worth $68,000 after purchasing an additional 735 shares during the period. Nisa Investment Advisors LLC lifted its stake in Cardiovascular Systems by 54.3% during the first quarter. Nisa Investment Advisors LLC now owns 3,495 shares of the medical device company's stock worth $79,000 after purchasing an additional 1,230 shares during the period. Finally, Point72 Hong Kong Ltd bought a new position in Cardiovascular Systems during the fourth quarter worth about $74,000. Institutional investors own 91.24% of the company's stock.
Cardiovascular Systems Stock Up 2.1 %
Shares of NASDAQ CSII traded up $0.35 during mid-day trading on Friday, hitting $16.64. The company had a trading volume of 177,636 shares, compared to its average volume of 291,714. The company has a quick ratio of 5.19, a current ratio of 6.05 and a debt-to-equity ratio of 0.08. The business's 50-day simple moving average is $15.20 and its 200-day simple moving average is $17.76. Cardiovascular Systems has a 12 month low of $13.41 and a 12 month high of $38.52.About Cardiovascular Systems
(Get Rating)
Cardiovascular Systems, Inc, a medical device company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.
Recommended Stories
- Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
- 2 Important Retail Stock Battles to Watch
- MarketBeat: Week in Review 8/8 – 8/12
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutions And Analysts Propel Jack In The Box Higher
- Can You Guess Which EV Stock Is Beating Tesla ?
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.
Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) saw a significant growth in short interest in the month of July. As of July 31st, there was short interest totalling 1,450,000 shares, a growth of 17.9% from the July 15th total of 1,230,000 shares. Based on an average trading volume of 345,500 shares, the short-interest ratio is presently 4.2 days. Approximately 4.3% of the shares of the company are short sold.
心血管系統公司(納斯達克代碼:CSII-GET評級)7月份空頭股數業務實現顯著增長。截至7月31日,空頭股數共有1,45萬股,較7月15日的1,230,000股增長17.9%。以平均成交量345,500股計算,目前短息比率為4.2天。該公司約4.3%的股份被賣空。
Insider Buying and Selling at Cardiovascular Systems
心血管系統的內部買入和賣出
In other news, CFO Jeffrey S. Points purchased 3,000 shares of the firm's stock in a transaction on Friday, May 20th. The stock was bought at an average cost of $14.50 per share, for a total transaction of $43,500.00. Following the completion of the acquisition, the chief financial officer now directly owns 109,312 shares of the company's stock, valued at $1,585,024. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 3.00% of the company's stock.
另一則消息是,首席財務官傑弗裏·S·伯恩斯在5月20日星期五的一次交易中購買了該公司3,000股股票。這隻股票的平均價格為每股14.50美元,交易總額為43,500.00美元。收購完成後,首席財務官現在直接擁有公司股票109,312股,價值1,585,024美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過美國證券交易委員會網站獲得。公司內部人士持有該公司3.00%的股份。
Institutional Investors Weigh In On Cardiovascular Systems
機構投資者參與心血管系統
Several hedge funds have recently made changes to their positions in the stock. Signaturefd LLC lifted its stake in Cardiovascular Systems by 8,110.3% during the first quarter. Signaturefd LLC now owns 2,381 shares of the medical device company's stock worth $54,000 after purchasing an additional 2,352 shares during the period. Acadian Asset Management LLC lifted its stake in Cardiovascular Systems by 294.7% during the fourth quarter. Acadian Asset Management LLC now owns 2,684 shares of the medical device company's stock worth $50,000 after purchasing an additional 2,004 shares during the period. PNC Financial Services Group Inc. lifted its stake in Cardiovascular Systems by 32.1% during the first quarter. PNC Financial Services Group Inc. now owns 3,025 shares of the medical device company's stock worth $68,000 after purchasing an additional 735 shares during the period. Nisa Investment Advisors LLC lifted its stake in Cardiovascular Systems by 54.3% during the first quarter. Nisa Investment Advisors LLC now owns 3,495 shares of the medical device company's stock worth $79,000 after purchasing an additional 1,230 shares during the period. Finally, Point72 Hong Kong Ltd bought a new position in Cardiovascular Systems during the fourth quarter worth about $74,000. Institutional investors own 91.24% of the company's stock.
幾家對衝基金最近改變了他們在該股的頭寸。Signaturefd LLC在第一季度將其在心血管系統公司的股份增加了8110.3%。Signaturefd LLC在此期間又購買了2352股,現在擁有2381股這家醫療器械公司的股票,價值5.4萬美元。Acadian Asset Management LLC在第四季度將其在心血管系統公司的持股增加了294.7%。Acadian Asset Management LLC在此期間又購買了2,004股,現在擁有2,684股這家醫療器械公司的股票,價值50,000美元。今年第一季度,PNC金融服務集團(PNC Financial Services Group Inc.)增持了32.1%的心血管系統股份。PNC金融服務集團(PNC Financial Services Group Inc.)在此期間又購買了735股,目前持有這家醫療設備公司3,025股股票,價值6.8萬美元。NISA Investment Advisors LLC在第一季度增持了54.3%的心血管系統股份。NISA Investment Advisors LLC在此期間又購買了1230股,現在擁有3495股這家醫療設備公司的股票,價值7.9萬美元。最後,Point72 Hong Kong Ltd在第四季度購買了一份新的心血管系統頭寸,價值約74,000美元。機構投資者持有該公司91.24%的股票。
Cardiovascular Systems Stock Up 2.1 %
心血管系統股票上漲2.1%
About Cardiovascular Systems
關於心血管系統
(Get Rating)
(獲取評級)
Cardiovascular Systems, Inc, a medical device company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.
心血管系統公司是一家醫療設備公司,在美國和國際上開發和銷售治療外周和冠狀動脈疾病的解決方案。該公司提供外周動脈疾病產品,這是基於導管的平臺,用於治療膝蓋以上和膝蓋以下的各種斑塊類型,包括鈣化斑塊,以及解決與手術、導管和藥物治療替代方案相關的各種限制;以及外周支持產品。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
- 2 Important Retail Stock Battles to Watch
- MarketBeat: Week in Review 8/8 – 8/12
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutions And Analysts Propel Jack In The Box Higher
- Can You Guess Which EV Stock Is Beating Tesla ?
- 免費獲取StockNews.com心血管系統研究報告(CSII)
- 值得關注的兩場重要的零售股大戰
- MarketBeat:回顧中的一週2012-8-8
- 什麼是WallStreetBets,他們的目標是什麼股票?
- 機構和分析師推動Jack in the Box走高
- 你能猜到哪個電動車股票打敗了特斯拉嗎?
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.
接受《每日心血管系統》新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對心血管系統和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧